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Background
The ability to induce a broadly neutralizing antibody
(bNAb) response following vaccination is regarded as a
crucial aspect in developing an effective HIV-1 vaccine.
This study describes the design and construction of a
subtype C founder virus consensus Env immunogen
derived from newly transmitted/founder virus sequences,
and its immunogenicity testing in the presence or
absence of liganded CD4, in small animals.
Methods
Monomeric (gp120), dimeric (gp120GCN4) and trimeric
(gp140GCN4 +/-) founder virus conformations were
expressed in mammalian cell culture. Unliganded or
2dCD4S60C liganded Env glycoproteins were purified by
lectin affinity chromatography, followed by conforma-
tion and complex purification using size exclusion chro-
matography. Immunogens/immune complexes were
evaluated by ELISA, SDS-PAGE, Native PAGE and Sur-
face Plasmon Resonance. Immunogenicity of each con-
formation alone or complexed to 2dCD4S60C was
evaluated in rabbits. Breadth and potency of the rabbit
sera was tested against 12 pseudoviruses (Tiers 1-3),
derived from HIV-1 subtype B and C Env, using the
PhenoSense Neutralizing antibody assay (Monogram
Bioscience Inc.).
Results
Minimal neutralizing breadth was obtained from animals
immunized exclusively with Env conformations. However,
animals that received the Env/2dCD4S60C complex showed
extensive neutralizing capacity against all 12 viruses tested,
including the tier 2 and 3 virus strains. End-point ELISA
titre results revealed that the rabbits that were immunized
with Env/2dCD4S60C produced both Env and 2dCD4 spe-
cific titres, but those directed towards 2dCD4 were on
average 10x lower than the 2dCD4 control group. This
implies a proportion of the neutralizing antibody activity is
directed towards conserved epitopes exposed on the Env/
2dCD4S60C immunogens.
Conclusion
The ability to induce bNAb activity in previous immuni-
zation studies utilizing Env/CD4 complexes was attribu-
ted to the induction of high anti-CD4 titres. By contrast,
in our study the relatively low anti-CD4 titres compared
to anti-Env titres and neutralization profiles suggest an
alternative mechanism of neutralization other than a
response directed to CD4 alone.
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